Grifols SA reports results for the quarter ended in September 30 - Earnings Summary

• Grifols SA GRFS.OQ reported quarterly adjusted earnings of 16 cents​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of 11 cents. The mean expectation of two analysts for the quarter was for earnings of 22 cents per share. Wall Street expected results to range from 21 cents to 22 cents per share.

• Revenue rose 12.2% to €1.79 billion from a year ago; analysts expected $1.73 billion.

• Grifols SA's reported EPS for the quarter was 8 cents​.

• The company reported quarterly net income of $51.69 million.

• Grifols SA shares had risen by 1.9% this quarter and lost 21.7% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 2.7% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 5 "hold" and 1 "sell" or "strong sell."

• The average consensus recommendation for the pharmaceuticals peer group is "hold."

Wall Street's median 12-month price target for Grifols SA is 11.13

This summary was machine generated from LSEG data November 7 at 08:42 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)